News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News After healthcare defeat, markets fear Trump's tax plans will... Trump could use executive powers to undermine system.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.